Timely access to diagnostics for ovarian and colorectal cancers will be tracked as part of 28 new proposed indicators to monitor CCGs' performance.
These will measure how many women with raised CA125 levels have an ultrasound within two weeks, and how many colon cancer patients receive diagnostic colonoscopy.
Other indicators will cover asthma deaths, antenatal care and diabetes care for children.
The measures are proposed as part of the CCG Outcomes Indicator framework for 2015/16. The framework benchmarks performance to help CCGs improve care outcomes, and hold them publicly to account.
NICE has launched a consultation on the proposals, which ends on Monday 3 March. A final indicator set will be sent to NHS England for approval in the autumn.